U.S. markets close in 1 hour 34 minutes
  • S&P 500

    4,404.46
    +3.00 (+0.07%)
     
  • Dow 30

    34,966.82
    -91.70 (-0.26%)
     
  • Nasdaq

    14,754.46
    +93.88 (+0.64%)
     
  • Russell 2000

    2,214.25
    +22.41 (+1.02%)
     
  • Crude Oil

    72.43
    +0.78 (+1.09%)
     
  • Gold

    1,797.30
    -2.50 (-0.14%)
     
  • Silver

    24.85
    +0.21 (+0.84%)
     
  • EUR/USD

    1.1812
    -0.0014 (-0.12%)
     
  • 10-Yr Bond

    1.2540
    +0.0200 (+1.62%)
     
  • GBP/USD

    1.3883
    +0.0004 (+0.03%)
     
  • USD/JPY

    110.1160
    +0.3490 (+0.32%)
     
  • BTC-USD

    39,609.25
    +1,934.12 (+5.13%)
     
  • CMC Crypto 200

    927.99
    -1.94 (-0.21%)
     
  • FTSE 100

    7,016.63
    +20.55 (+0.29%)
     
  • Nikkei 225

    27,581.66
    -388.56 (-1.39%)
     

We Think Bio-Path Holdings (NASDAQ:BPTH) Can Afford To Drive Business Growth

·4 min read

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse.

Given this risk, we thought we'd take a look at whether Bio-Path Holdings (NASDAQ:BPTH) shareholders should be worried about its cash burn. For the purpose of this article, we'll define cash burn as the amount of cash the company is spending each year to fund its growth (also called its negative free cash flow). We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.

Check out our latest analysis for Bio-Path Holdings

Does Bio-Path Holdings Have A Long Cash Runway?

A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. When Bio-Path Holdings last reported its balance sheet in March 2021, it had zero debt and cash worth US$31m. Importantly, its cash burn was US$10.0m over the trailing twelve months. So it had a cash runway of about 3.1 years from March 2021. A runway of this length affords the company the time and space it needs to develop the business. The image below shows how its cash balance has been changing over the last few years.

debt-equity-history-analysis
debt-equity-history-analysis

How Is Bio-Path Holdings' Cash Burn Changing Over Time?

Because Bio-Path Holdings isn't currently generating revenue, we consider it an early-stage business. So while we can't look to sales to understand growth, we can look at how the cash burn is changing to understand how expenditure is trending over time. With the cash burn rate up 12% in the last year, it seems that the company is ratcheting up investment in the business over time. That's not necessarily a bad thing, but investors should be mindful of the fact that will shorten the cash runway. While the past is always worth studying, it is the future that matters most of all. So you might want to take a peek at how much the company is expected to grow in the next few years.

Can Bio-Path Holdings Raise More Cash Easily?

Given its cash burn trajectory, Bio-Path Holdings shareholders may wish to consider how easily it could raise more cash, despite its solid cash runway. Companies can raise capital through either debt or equity. Many companies end up issuing new shares to fund future growth. We can compare a company's cash burn to its market capitalisation to get a sense for how many new shares a company would have to issue to fund one year's operations.

Since it has a market capitalisation of US$42m, Bio-Path Holdings' US$10.0m in cash burn equates to about 24% of its market value. That's fairly notable cash burn, so if the company had to sell shares to cover the cost of another year's operations, shareholders would suffer some costly dilution.

Is Bio-Path Holdings' Cash Burn A Worry?

On this analysis of Bio-Path Holdings' cash burn, we think its cash runway was reassuring, while its cash burn relative to its market cap has us a bit worried. Considering all the factors discussed in this article, we're not overly concerned about the company's cash burn, although we do think shareholders should keep an eye on how it develops. Separately, we looked at different risks affecting the company and spotted 5 warning signs for Bio-Path Holdings (of which 2 are concerning!) you should know about.

Of course Bio-Path Holdings may not be the best stock to buy. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.